Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2 results about "Nocardia" patented technology

Nocardia is a genus of weakly staining Gram-positive, catalase-positive, rod-shaped bacteria. It forms partially acid-fast beaded branching filaments (acting as fungi, but being truly bacteria). It contains a total of 85 species. Some species are nonpathogenic, while others are responsible for nocardiosis. Nocardia species are found worldwide in soil rich in organic matter. In addition, they are oral microflora found in healthy gingiva, as well as periodontal pockets. Most Nocardia infections are acquired by inhalation of the bacteria or through traumatic introduction.

Nocardia-like strain n25 for complete degradation of don and its use in degradation of fusarium toxins

The application discloses a strain of completely degrading deoxynivalenol (DON), the N25 Nocardioides, the preservation number of the strain being CCTCC M 20252560. Average nucleotide identity (ANI) analysis shows that the strain is a new species in the Nocardioides genus, the strain can utilize DON toxin as a sole carbon source, and can completely degrade the DON toxin to form CO2 and H2O, completely eliminating the toxic effect, and can also degrade a plurality of fusarium toxins including A-type trichothecene toxin neosolensaric acid (NEO) and B-type trichothecene toxin 3-acetyl-DON (3-Ac-DON), nivalenol (NIV) and fusarenon-X (FUS-X). Therefore, the strain has a wide application prospect in the field of fusarium toxin detoxification.
Owner:HUAZHONG AGRI UNIV

A primer probe combination for detecting nocardia, mycobacterium tuberculosis complex and mycobacterium, a kit and application thereof

The application discloses a primer probe combination, a kit and application for detecting Nocardia, a mycobacterium tuberculosis complex and mycobacterium, and belongs to the technical field of genetic engineering. The technical problem to be solved is that there is a lack of a nucleic acid detection tool for Nocardia, the mycobacterium tuberculosis complex and mycobacterium in the prior art, which is high in sensitivity, high in specificity and simple in operation. The technical solution is characterized in that the primer probe combination comprises a primer probe for detecting Nocardia, a primer probe for detecting the mycobacterium tuberculosis complex, a primer probe for detecting mycobacterium and a primer probe for detecting an internal standard control. The primer probe combination can simultaneously screen Nocardia, the mycobacterium tuberculosis complex and mycobacterium, quickly and simply confirms pathogenic species, saves time, manpower and reagent cost, and has the advantages of high specificity, a low minimum detection limit and prevention of false negative or false positive results.
Owner:北京卓诚惠生生物科技股份有限公司